Ketamine Not Yet Recruiting Phase 3 Trials for Analgesia / Vaso-occlusive Crisis / Vaso-Occlusive Pain Episode in Sickle Cell Disease / Intranasal Ketamine / Sickle Cell Disease (SCD) / Ketamine Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04150757Intranasal Ketamine For Pain Control In Patients With Sickle Cell Disease And Vaso-occlusive Episode (VOE) In The PED